Ratings DukSan Neolux Co.,Ltd

Equities

A213420

KR7213420003

End-of-day quote Korea S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
45,250 KRW +0.33% Intraday chart for DukSan Neolux Co.,Ltd +10.10% +1.69%

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.

Weaknesses

  • The firm trades with high earnings multiples: 23.91 times its 2024 earnings per share.
  • The company's enterprise value to sales, at 5315.83 times its current sales, is high.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

Ratings chart - Surperformance

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
+1.69% 804M -
+17.07% 66.31B
A-
-0.29% 48.46B
A-
+21.61% 43.27B
B+
+26.72% 27.41B
A-
+9.25% 19.26B
C+
-2.14% 16.61B
B+
+9.75% 16.58B
B+
-15.01% 14.41B
C+
-30.22% 14.02B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. A213420 Stock
  4. Ratings DukSan Neolux Co.,Ltd